 catalytic doses fructose benefit glycaemic control harming cardiometabolic risk factors small meta-analysis randomised controlled feeding trials abstract contrary concerns fructose adverse metabolic effects evidence small catalytic doses num g/meal fructose decrease glycaemic response high-glycaemic index meals human subjects assess longer-term effects catalytic doses fructose undertook meta-analysis controlled feeding trials searched medline embase cinahl cochrane library analyses included controlled feeding trials num featuring catalytic fructose doses num g/d isoenergetic exchange carbohydrates data pooled generic inverse variance method random-effects models expressed differences md num ci heterogeneity assessed statistic quantified num heyland methodological quality score assessed study quality total feeding trials num met eligibility criteria catalytic doses fructose significantly reduced hba num md num num ci num num num num fasting glucose md num num ci num num num num benefit absence adverse effects fasting insulin body weight tag uric acid subgroup sensitivity analyses showed evidence effect modification conditions small number trials short duration limit strength conclusions conclusion small meta-analysis shows catalytic fructose doses num g/d improve glycaemic control adverse effects body weight tag insulin uric acid larger longer num months trials catalytic fructose confirm results 
